AGT and heart failure: In complementary studies involving comparisons with published Illumina and RNA‐Seq data from normal and human heart failure, we show that angiotensin II (AngII) treatment of mouse cardiomyocytes induces many of the transcriptomic changes observed in human heart failure, and that treatment of AngII‐exposed cardiomyocytes with ldCil restores these transcriptomic changes back towards those found in normal human heart transcriptomic profiles.